IFI-P · Carvacrol Series

Specimen SS-F-TRP-565 // PUNGENT · IFI-P

Carvacrol Series I-PR-A

Origanum vulgare

Oregano

Tier ICarvacrol Series

Target Trait

1.3×

fold-change

Carvacrol TRPA1 agonist fold-change

Technical Specifications

SKU

SS-F-TRP-565

Genomic Edits

3

GC Content

48.5%

Construct Length

2,376 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPA1

IFI Score

130

Pathway Edits

  • CYP71D (carvacrol synthase P450) upregulation for para-cymene hydroxylation to carvacrol in Origanum vulgare
  • SABATH methyltransferase suppression to prevent carvacrol O-methylation to thymyl methyl ether byproduct
  • GPP synthase overexpression for expanded geranyl diphosphate pool feeding oregano monoterpene biosynthesis

Key Interventions

CYP71D/para-cymene synthase cascade amplification for high-yield carvacrol biosynthesis in Origanum vulgare glandular trichomesSABATH methyltransferase suppression maintains free carvacrol in the phenol form required for TRPA1 non-covalent electrophilic activationCarvacrol TRPA1 agonism confirmed by IFI-P calcium-flux assay; characteristic warm, spicy-herbal oregano pungency profile validated in sensory panel cohortPEG-mediated transient expression protocol validated for rapid phenotypic pathway screening

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
130
IFI-A
—
IFI-F
—

Use Case

Tier I carvacrol-enriched oregano ingredient platform for Mediterranean flavor formulation, pizza and tomato sauce flavor standardization, TRPA1-targeted herbal pungency in dressings and marinades, and functional food applications leveraging carvacrol's well-characterized antimicrobial and flavor properties. Suitable for manufacturers requiring consistent essential oil phenol content independent of Origanum vulgare geographic or seasonal chemotype variability.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Pungent · IFI-PAll Modalities